Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides

The maleimide motif is widely used for the selective chemical modification of cysteine residues in proteins. Despite widespread utilization, there are some potential limitations, including the irreversible nature of the reaction and, hence, the modification and the number of attachment positions. We conceived of a new class of maleimide which would address some of these limitations and provide new opportunities for protein modification. We report herein the use of mono- and dibromomaleimides for reversible cysteine modification and illustrate this on the SH2 domain of the Grb2 adaptor protein (L111C). After initial modification of a protein with a bromo- or dibromomaleimide, it is possible to add an equivalent of a second thiol to give further bioconjugation, demonstrating that bromomaleimides offer opportunities for up to three points of attachment. The resultant protein−maleimide products can be cleaved to regenerate the unmodified protein by addition of a phosphine or a large excess of a thiol. Furthermore, dibromomaleimide can insert into a disulfide bond, forming a maleimide bridge, and this is illustrated on the peptide hormone somatostatin. Fluorescein-labeled dibromomaleimide is synthesized and inserted into the disulfide to construct a fluorescent somatostatin analogue. These results highlight the significant potential for this new class of reagents in protein modification.

[1]  David R. Walt,et al.  Intramolecular fluorescence self-quenching of fluoresceinamine , 1990 .

[2]  P. Freda Somatostatin analogs in acromegaly. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[4]  Joel A Swanson,et al.  Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. , 2003, Advanced drug delivery reviews.

[5]  J. D. Gregory The Stability of N-Ethylmaleimide and its Reaction with Sulfhydryl Groups , 1955 .

[6]  S. Brocchini,et al.  Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. , 2007, Bioconjugate chemistry.

[7]  S. Brocchini,et al.  Site-specific PEGylation of native disulfide bonds in therapeutic proteins , 2006, Nature chemical biology.

[8]  B. Frisch,et al.  Differential reactivity of maleimide and bromoacetyl functions with thiols: application to the preparation of liposomal diepitope constructs. , 2000, Bioconjugate chemistry.

[9]  Mire Zloh,et al.  Disulfide bridge based PEGylation of proteins. , 2008, Advanced drug delivery reviews.

[10]  S. Al-Karadaghi,et al.  Occurrence, conformational features and amino acid propensities for the pi-helix. , 2002, Protein engineering.

[11]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[12]  B. G. Davis,et al.  Chemical modification of proteins at cysteine: opportunities in chemistry and biology. , 2009, Chemistry, an Asian journal.

[13]  R. Bednar,et al.  Reactivity and pH dependence of thiol conjugation to N-ethylmaleimide: detection of a conformational change in chalcone isomerase. , 1990, Biochemistry.

[14]  M. Viaud-Massuard,et al.  Synthesis of substituted bis(heteroaryl)maleimides , 2005 .

[15]  K. Öberg Somatostatin analog octreotide LAR® in gastro–entero–pancreatic tumors , 2009 .

[16]  Glenn D Prestwich,et al.  Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. , 2007, Biomacromolecules.